MedTrace Logo

DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution

NCT05389774 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-04-08

No results posted yet for this study

Summary

This study is a multi-centre prospective observational cohort study recruiting patients with 5-30mm solid and part-solid pulmonary nodules that have been detected on CT chest scans performed as part of routine practice. The aim is to determine whether physician decision making with the AI-based LCP tool, generates clinical and health-economic benefits over the current standard of care of these patients.

Conditions

  • AI (Artificial Intelligence)
  • Pulmonary Nodule, Solitary
  • Pulmonary Nodule, Multiple
  • Lung Cancer

Sponsors & Collaborators

  • Optellum Ltd.

    collaborator UNKNOWN

  • Nottingham University Hospitals NHS Trust

    lead OTHER

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-23
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05389774 on ClinicalTrials.gov